HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.1
  1. Home
  2. /Compound

Staurosporine

HCID 44259
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
62996-74-1
Standard SMILES
CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4
InChIKey
HKSZLNNOFSGOKW-FYTWVXJKSA-N
Molecular formula
C28H26N4O3
Average molar mass
466.5 g/mol
Monoisotopic mass
466.20049069

Overview

Staurosporine is an indolocarbazole alkaloid and an organic heterooctacyclic compound. It has a role as a geroprotector, an EC 2.7.11.13 (protein kinase C) inhibitor, an apoptosis inducer and a bacterial metabolite. It is a conjugate base of a staurosporinium.

Names & identifiers

Preferred name
Staurosporine
IUPAC
(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
English name
STAUROSPORINE
Molecular formula
C28H26N4O3
Molecular weight
466.54

Names & synonyms

staurosporineStaurosporin62996-74-1Antibiotic 230Antibiotic AM 2282AM-2282H88EPA0A3NDTXSID6041131CHEBI:15738CGP-393608,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
Show more names
STSPStauroporineStaurosporine,98%2,3,10,11,12,13-HEXAHYDRO-10R-METHOXY-9S-METHYL-11R-METHYLAMINO-9S,13R-EPOXY-1H,9H-DIINDOLO[1,2,3-GH:3',2',1'-LM]PYRROLO[3,4-J][1,7]BENZODIAZONIN-1 ONECBR113CS-2206SporosinCGP 39360
NSC618487(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo(12.12.2.1^(2,6).0^(7,28).0^(8,13).0^(15,19).0^(20,27).0^(21,26))nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-16-one(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo(12.12.2.12,6.07,28.08,13.015,19.020,27.021,26)nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-16-oneRefChem:889116DTXCID201340061(9alpha,10beta,11beta,13alpha)-(+)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H-9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-1-one1-((2R,3S,4S,6S)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo(12.12.2.12,6.07,28.08,13.015,19.020,27.021,26)nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl)-1-methylurea

Properties

Computed structural propertiesFilling in

XLogP
3.2
Topological polar surface area
69.5 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
2
Heavy atoms
35
Formal charge
0
Complexity
901

Experimental & physicochemical properties

Drugs · 2 items

Pharmaceuticals -> Antibiotics

Pharmaceuticals -> Listed in ZINC15

Physicochemical properties

Melting point
270 °C · 270°C
alpha
25 · D25 +35.0° (c = 1 in methanol); D22 +56.1° (c = 0.14 in methanol)
Boiling point
677.5 · 677.5±55.0 °C(Predicted)
Density
1.56 · 1.56±0.1 g/cm3(Predicted)
RTECS
5084000 · KD5084000
storage temp.
2 · 2-8°C
solubility
DMSO: soluble
form
White to pale yellow solid
pka
14.25 · 14.25±0.70(Predicted)
color
Off white to pale yellow
Water Solubility
Soluble in DMSO or ethanol.Soluble in dimethyl sulfoxide , dimethyl formamide, ethyl acetate, hot acetone and ethanol. Slightly soluble in chloroform and methanol. Insoluble in water.

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (10%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P260, P264, P270, P273, P280, P301+P317, P318, P319, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 10 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 1 item

9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, (9S,10R,11R,13R)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.

Hazard Classes and CategoriesAcute Tox. 4 (10%)

Safety data

F
8-10
PPE
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
wgk
2
ridadr
UN 2811 6.1 / PGII
hs_code
29419090
risk_code
40-45-36/37/38-46
Signal word
Warning
Symbol(GHS)
GHS08
hazard_code
Xn,T,Xi
safety_code
36/37-53-36-26-45
hazard_class
3

Chemistry & industry

Pharmacology

MeSH Pharmacological ClassificationCompounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction.
Applications · 5 items

DescriptionStaurosporine (Stsp) is potent inhibitor of protein kinase C (PKC) from rat brain, exhibiting an IC50 value of 2.7 nM. It inhibits rat recombinant PKC-α approximately 100- and 1,000-fold better than PKC-δ and PKC-ζ, respectively. However, Stsp is non-selective in that it also inhibits the activity of a variety of other protein kinases, not only PKC isoforms. The biological effects of Stsp include cytotoxicity, relaxation of smooth muscle, and regulation of eNOS gene expression.

OccurrenceA complex alkaloid. staurosporine has been isolated from a strain of Streptomyces.

UsesStaurosporine is an unusual indolocarbazole alkaloid produced by a range of actinomycete species. It is a potent antitumour active, inducing apoptosis in a variety of cell lines. Staurosporine is a potent inhibitor of many kinases including protein kinase C, tyrosine kinase, CDK2/cyclin A and CDK4/cyclin D. At submicromolar concentrations, staurosporine inhibits both IKKalpha and IKKbeta.

UsesStaurosporine is a protein Kinase C inhibitor that induces apoptosis in many cell types.

General DescriptionA potent, cell-permeable, reversible, ATP-competitive and broad spectrum inhibitor of protein kinases. Inhibits CaM kinase (IC50 = 20 nM), myosin light chain kinase (IC50 = 1.3 nM), protein kinase A (IC50 = 7 nM), protein kinase C (IC50 = 0.7 nM), and protein kinase G (IC50 = 8.5 nM). Also inhibits platelet aggregation induced by collagen or ADP but has no effect on thrombin-induced platelet aggregation. Induces apoptosis in human malignant glioma cell lines. Arrests normal cells at the G1 checkpoint.

Upstream & downstream products

Upstream raw materials

9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one, 2-[(3,4-dimethoxyphenyl)methyl]-2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-, [9S-(9α,10β,11β,13α)]- (9CI)

Related reactions

1,154 records
New reaction record
HRID 438032 reaction equation
HRID 438032As productAs reactantCernak miniaturized reductive amination
HRID 438033 reaction equation
HRID 438033As productAs reactantCernak miniaturized reductive amination
HRID 438034 reaction equation
HRID 438034As productAs reactantCernak miniaturized reductive amination
HRID 438035 reaction equation
HRID 438035As productAs reactantCernak miniaturized reductive amination
HRID 438036 reaction equation
HRID 438036As productAs reactantCernak miniaturized reductive amination
HRID 438037 reaction equation
HRID 438037As productAs reactantCernak miniaturized reductive amination
HRID 438038 reaction equation
HRID 438038As productAs reactantCernak miniaturized reductive amination
HRID 438039 reaction equation
HRID 438039As productAs reactantCernak miniaturized reductive amination
PreviousPage 1 of 145

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
62996-74-1
PubChem CID
44259
DTXSID
DTXSID6041131
ChEMBL
CHEMBL388978
ChEBI
CHEBI:15738
UNII
H88EPA0A3N
EC Number
613-127-7
Nikkaji
J445.409J
BRN
1060573 · 1060573
Stability
1 year · Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 4 months.
InChIKey
HKSZLNNOFSGOKW-WIFUGMKFSA-N
SMILES
CN[C@@H]1C[C@@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35
CAS DataBase Reference
62996 · 62996-74-1
NCI Dictionary of Cancer Terms
staurosporine
FDA UNII
88 EPA0A3N · H88EPA0A3N
UNSPSC Code
12352200 · 12352200
NACRES
77 · NA.77
Symbol(GHS)
8 · GHS08
Signal word
Warning
Hazard statements
361 d-H413 · H361d-H413
Precautionary statements
201 · P201-P202-P273-P280-P308+P313-P405
PPE
3 · Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Hazard Codes
Xn,T,Xi
Risk Statements
40 · 40-45-36/37/38-46
Safety Statements
36 · 36/37-53-36-26-45
RIDADR
2811 · UN 2811 6.1 / PGII
WGK Germany
2 · 2
F
8 · 8-10
HazardClass
3 · 3
HS Code
29419090 · 29419090
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
4 Carc · Aquatic Chronic 4Carc. 1BMuta. 1BRepr. 2
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard statements
H361d-H413
Hazard Classifications
Aquatic Chronic 4Carc. 1BMuta. 1BRepr. 2
Precautionary statements
P201-P202-P273-P280-P308+P313-P405
9,13-Epoxy-1H,11H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonine-1,11-dione, 2-[(3,4-dimethoxyphenyl)methyl]-2,3,9,10,12,13-hexahydro-10-methoxy-9-methyl-, 11-(O-methyloxime), [9S-(9α,10β,11Z,13α)]- (9CI)
Additional notes · 1 item

DefinitionChEBI: Staurosporine is an indolocarbazole alkaloid and an organic heterooctacyclic compound. It has a role as an EC 2.7.11.13 (protein kinase C) inhibitor, a geroprotector, a bacterial metabolite and an apoptosis inducer. It is a conjugate base of a staurosporinium.